A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib
Clinical trial NCT05665192 · COMPLETED
Trial details
- NCT number
- NCT05665192
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-02
- Primary completion
- 2023-07-24
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.